Skip to main content
OpenTrials
Completed

NCT Number: NCT02619604

A Quality Improvement Approach to the Management of Chronic Lymphocytic Leukemia

This project addresses the need to improve physician knowledge and clinical practice patterns related to quality of life (QoL) concerns for patients with chronic lymphocytic leukemia (CLL).

Completed

Looking for future studies?

Notify Me

Key information

About this study

This multifaceted initiative will include evaluating patient perspectives on their QoL, evaluating provider perspectives on managing QoL, and providing education to the whole CLL care team (hematologists/oncologists, nurse practitioners, physician assistants, and nurses) on contemporary approaches for individualized, patient-centered management of CLL. Providers, including physicians, nurse practitioners, and physician assistants will participate in educational initiatives geared towards enhancing their knowledge and confidence with managing QoL concerns for patients with CLL. Pre and post surveys will be conducted with providers to evaluate change in these areas. The project aims to train this team on how to enhance communication with patients and caregivers as a means to increase patient engagement in care and QoL in this population.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Clinician

  • Participant must be a hematologist, oncologist, nurse practitioner, or physician assistant who practices medicine in the Duke Cancer Network
  • Participant treats patients with CLL
  • Participant is willing to participate in the educational component of this project

Inclusion criteria

Patient

  • Patient has a diagnosis of Chronic Lymphocytic Leukemia
  • Patient is over the age of 18
  • Patient is being treated at a Duke Cancer Network affiliate site,
  • Patient is expected to see their physician or another member of their care team at least 3 times annually.
  • Signed informed consent

Exclusion criteria

Clinician

  • None

Exclusion criteria

Patient

  • Patient is Non-English speaking
  • Patient diagnosed with CLL < 60 days ago

Treatment and study plan

Education Intervention

Other

Education interventions will be delivered sporadically within the 6-month window between the time the clinician completes the pre-survey and when he/she completes the post-survey. Interventions consist of e-brief publications, teleconferences with project faculty, and evidence based resources.

Primary outcomes

  1. Change in provider knowledge with management of Quality of Life Concerns for CLL patients, as measured by survey

    Time frame: Baseline, 6 months

  2. Change in provider confidence with management of Quality of Life Concerns for CLL patients, as measured by survey

    Time frame: Baseline, 6 months

Sponsors and collaborators

Lead sponsor

Duke University

Other

Collaborators

  • Genentech, Inc.
  • Gilead Sciences
  • Med-IQ

Registry information

Acronym: Med-IQ CLL

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Dec 2, 2015
Registry last updated
Feb 15, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.